Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing. - Foley GR; Marthick JR; Ostrander EA; Stanford JL; Dickinson JL; FitzGerald LM (European journal of cancer (Oxford, England : 1990), 2023)